These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8397919

  • 1. Fluconazole and itraconazole: current status and prospects for antifungal therapy.
    Sugar AM.
    Curr Clin Top Infect Dis; 1993; 13():74-98. PubMed ID: 8397919
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Choice and use of the new antifungal agents].
    Meyer RD.
    Rev Clin Esp; 1994 Feb; 194(2):116-27. PubMed ID: 8008935
    [No Abstract] [Full Text] [Related]

  • 6. Clinical relevance of antifungal resistance.
    Espinel-Ingroff A.
    Infect Dis Clin North Am; 1997 Dec; 11(4):929-44. PubMed ID: 9421708
    [Abstract] [Full Text] [Related]

  • 7. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E, Espinel-Ingroff A, Szekely A, Hockey H, Troke P.
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [Abstract] [Full Text] [Related]

  • 8. [Antifungal agent resistance of yeasts of clinical significance].
    Odds FC.
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():56-7. PubMed ID: 9441307
    [No Abstract] [Full Text] [Related]

  • 9. [Current progress in antifungal therapy: the value of fluconazole].
    Meunier F.
    Rev Med Brux; 1990 Sep; 11(7):278-82. PubMed ID: 2218209
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A.
    Chemotherapy; 1987 Sep; 33(5):381-95. PubMed ID: 2822362
    [Abstract] [Full Text] [Related]

  • 13. [Systematic therapy of vaginal mycoses. Three quarters of women are affected].
    Gynakologe; 1994 Jun; 27(3 Suppl):1-4. PubMed ID: 9211662
    [No Abstract] [Full Text] [Related]

  • 14. [Drug therapy of intractable mycoses].
    Ikemoto H.
    Nihon Naika Gakkai Zasshi; 1990 Dec 10; 79(12):1680-4. PubMed ID: 2079591
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of itraconazole in haematology/oncology.
    Pandya NA, Atra AA, Riley U, Pinkerton CR.
    Arch Dis Child; 2003 Mar 10; 88(3):258-60. PubMed ID: 12598396
    [Abstract] [Full Text] [Related]

  • 17. [Therapy of Systemic Mycoses: Candidiasis, Aspergillosis, Cryptococcosis. Role of Itraconazol. Symposium. Hamburg, 10 June 1994].
    Mycoses; 1994 Mar 10; 37 Suppl 2():1-82. PubMed ID: 7609738
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of invasive fungal infections in immunocompromised patients with fluconazole.
    Esposito R, Uberti Foppa C, Cernuschi M.
    J Chemother; 1989 Jul 10; 1(4 Suppl):925-6. PubMed ID: 16312707
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.